Agency Information Collection Activities: Submission for OMB Review; Comment Request, 465-466 [2021-28564]
Download as PDF
TKELLEY on DSK125TN23PROD with NOTICE
Federal Register / Vol. 87, No. 3 / Wednesday, January 5, 2022 / Notices
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: George M. Barnas, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 2180,
MSC 7818, Bethesda, MD 20892, 301–435–
0696, barnasg@csr.nih.gov.
Name of Committee: Brain Disorders and
Clinical Neuroscience Integrated Review
Group; Pathophysiological Basis of Mental
Disorders and Addictions Study Section.
Date: February 2–3, 2022.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Boris P. Sokolov, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5217A,
MSC 7846, Bethesda, MD 20892, 301–408–
9115, bsokolov@csr.nih.gov.
Name of Committee: Risk, Prevention and
Health Behavior Integrated Review Group;
Biobehavioral Medicine and Health
Outcomes Study Section.
Date: February 7–8, 2022.
Time: 9:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Mark A. Vosvick, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3110,
Bethesda, MD 20892, (301) 402–4128,
mark.vosvick@nih.gov.
Name of Committee: Bioengineering
Sciences & Technologies Integrated Review
Group; Modeling and Analysis of Biological
Systems Study Section.
Date: February 8–9, 2022.
Time: 10:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Noffisat Oki, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD
20892, 240–627–3648, noffisat.oki@nih.gov.
Name of Committee: Integrative,
Functional and Cognitive Neuroscience
Integrated Review Group; Neuroscience of
Basic Visual Processes Study Section.
Date: February 9–10, 2022.
Time: 10:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Kirk Thompson, Ph.D.,
Scientific Review Officer, Center for
VerDate Sep<11>2014
18:05 Jan 04, 2022
Jkt 256001
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5184,
MSC 7844, Bethesda, MD 20892, 301–435–
1242, kgt@mail.nih.gov.
Name of Committee: Biological Chemistry
and Macromolecular Biophysics Integrated
Review Group; Synthetic and Biological
Chemistry A Study Section.
Date: February 9–10, 2022.
Time: 10:00 a.m. to 6:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Anita Szajek, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4187,
Bethesda, MD 20892, 301–827–6276,
anita.szajek@nih.gov.
Name of Committee: Molecular, Cellular
and Developmental Neuroscience Integrated
Review Group; Neurogenesis and Cell Fate
Study Section.
Date: February 9–10, 2022.
Time: 11:00 a.m. to 9:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Christine Jean DiDonato,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 1014J,
Bethesda, MD 20892, (301) 435–1042,
didonatocj@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: December 29, 2021.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2021–28529 Filed 1–4–22; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
PO 00000
Frm 00042
Fmt 4703
Sfmt 4703
465
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; NIAID Clinical Trial
Planning Grant (R34); NIAID Clinical Trial
Implementation Cooperative Agreement
(U01); NIAID SBIR Phase II Clinical Trial
Implementation Cooperative Agreement
(U44); Investigator Initiated Extended
Clinical Trial (R01).
Date: February 3–4, 2022.
Time: 10:00 a.m. to 2:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute of Allergy and
Infectious Diseases, National Institutes of
Health, 5601 Fishers Lane, Room 3F21B,
Rockville, MD 20892 (Virtual Meeting).
Contact Person: Maryam Feili-Hariri,
Ph.D., Scientific Review Officer, Scientific
Review Program, Division of Extramural
Activities, National Institute of Allergy and
Infectious Diseases, National Institutes of
Health, 5601 Fishers Lane, Room 3F21B,
Rockville, MD 20852, 240–669–5026,
haririmf@niaid.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: December 29, 2021.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2021–28533 Filed 1–4–22; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Substance Abuse and Mental Health
Services Administration
Agency Information Collection
Activities: Submission for OMB
Review; Comment Request
Periodically, the Substance Abuse and
Mental Health Services Administration
(SAMHSA) will publish a summary of
information collection requests under
OMB review, in compliance with the
Paperwork Reduction Act (44 U.S.C.
Chapter 35). To request a copy of these
documents, call the SAMHSA Reports
Clearance Officer at (240) 276–0361.
Project: Substance Abuse Prevention
and Treatment Block Grant Synar
Report Format, FFY 2022–2024—(OMB
No. 0930–0222)—Extension
Section 1926 of the Public Health
Service Act [42 U.S.C. 300x–26]
stipulates that Substance Abuse
Prevention and Treatment Block Grant
(SABG) funding agreements for alcohol
E:\FR\FM\05JAN1.SGM
05JAN1
466
Federal Register / Vol. 87, No. 3 / Wednesday, January 5, 2022 / Notices
and drug abuse programs for fiscal year
1994 and subsequent fiscal years require
states to have in effect a law providing
that it is unlawful for any manufacturer,
retailer, or distributor of tobacco
products to sell or distribute any such
product to any individual under the age
of 21. This section further requires that
states conduct annual, random,
unannounced inspections to ensure
compliance with the law; that the state
submit annually a report describing the
results of the inspections, the activities
carried out by the state to enforce the
required law, the success the state has
achieved in reducing the availability of
tobacco products to individuals under
the age of 21, and the strategies to be
utilized by the state for enforcing such
law during the fiscal year for which the
grant is sought.
Before making an award to a state
under the SABG, the Secretary must
make a determination that the state has
maintained compliance with these
requirements. If a determination is made
that the state is not in compliance,
penalties shall be applied. According to
Public Law 116–94 (‘‘Tobacco 21’’),
signed on December 20, 2019, penalties
are capped at 10 percent. Respondents
include the 50 states, the District of
Columbia, the Commonwealth of Puerto
Rico, the U.S. Virgin Islands, Guam,
American Samoa, the Commonwealth of
the Northern Mariana Islands, Palau,
Micronesia, and the Marshall Islands.
Red Lake Indian Tribe is not subject to
tobacco requirements.
Regulations that implement this
legislation are at 45 CFR 96.130, are
approved by OMB under control
number 0930–0163, and require that
each state submit an annual Synar
report to the Secretary describing their
progress in complying with section 1926
of the PHS Act. The Synar report, due
December 31 following the fiscal year
for which the state is reporting,
describes the results of the inspections
and the activities carried out by the state
to enforce the required law; the success
the state has achieved in reducing the
availability of tobacco products to
individuals under the age of 21; and the
strategies to be utilized by the state for
enforcing such law during the fiscal
year for which the grant is sought.
SAMHSA’s Center for Substance Abuse
Prevention will request an extension of
OMB approval of the current report
format associated with section 1926 (42
U.S.C. 300x–26) to 2024. Extending
OMB approval of the current report
format will continue to facilitate
consistent, credible, and efficient
monitoring of Synar compliance across
the states.
ANNUAL REPORTING BURDEN
Total
number of
responses
Hours per
response
Total hour
burden
Annual Report (Section 1—States and Territories) 96.130(e)(1–3)
State
Plan
(Section
II—States
and
Territories)
6.130(e)(4,5)96.130(g) .................................................................
59
1
59
15
885
59
1
59
3
177
Total ..........................................................................................
59
........................
118
....................
1,062
Written comments and
recommendations for the proposed
information collection should be sent
within 30 days of publication of this
notice to www.reginfo.gov/public/do/
PRAMain. Find this particular
information collection by selecting
‘‘Currently under 30-day Review—Open
for Public Comments’’ or by using the
search function.
Carlos Graham,
Reports Clearance Officer.
[FR Doc. 2021–28564 Filed 1–4–22; 8:45 am]
BILLING CODE 4162–20–P
TKELLEY on DSK125TN23PROD with NOTICE
Responses
per
respondents
Number of
respondents 1
45 CFR citation
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Substance Abuse and Mental Health
Services Administration (SAMHSA)
Agency Information Collection
Activities: Proposed Collection;
Comment Request
In compliance with Section
3506(c)(2)(A) of the Paperwork
Reduction Act of 1995 concerning
opportunity for public comment on
proposed collections of information,
SAMHSA will publish periodic
summaries of proposed projects. To
request more information on the
proposed projects or to obtain a copy of
the information collection plans, call
the SAMHSA Reports Clearance Officer
on (240) 276–0361.
Comments are invited on: (a) Whether
the proposed collections of information
are necessary for the proper
performance of the functions of the
agency, including whether the
information shall have practical utility;
(b) the accuracy of the agency’s estimate
of the burden of the proposed collection
of information; (c) ways to enhance the
quality, utility, and clarity of the
information to be collected; and (d)
ways to minimize the burden of the
collection of information on
respondents, including leveraging
automated data collection techniques or
other forms of information technology.
Proposed Project: Community Mental
Health Services Block Grant and
Substance Abuse Prevention and
Treatment Block Grant FY 2022–2023
Plan and Report Guidance and
Instructions (OMB No. 0930–0168)—
Extension
SAMHSA is requesting approval from
the Office of Management and Budget
(OMB) for an extension of the 2020–21
Community Mental Health Services
Block Grant (MHBG) and Substance
Abuse Prevention and Treatment Block
Grant (SABG) Application Plan and
Report Guidance and Instructions.
1 Red Lake Indian Tribe is not subject to tobacco
requirements.
VerDate Sep<11>2014
18:05 Jan 04, 2022
Jkt 256001
PO 00000
Frm 00043
Fmt 4703
Sfmt 4703
E:\FR\FM\05JAN1.SGM
05JAN1
Agencies
[Federal Register Volume 87, Number 3 (Wednesday, January 5, 2022)]
[Notices]
[Pages 465-466]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-28564]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Substance Abuse and Mental Health Services Administration
Agency Information Collection Activities: Submission for OMB
Review; Comment Request
Periodically, the Substance Abuse and Mental Health Services
Administration (SAMHSA) will publish a summary of information
collection requests under OMB review, in compliance with the Paperwork
Reduction Act (44 U.S.C. Chapter 35). To request a copy of these
documents, call the SAMHSA Reports Clearance Officer at (240) 276-0361.
Project: Substance Abuse Prevention and Treatment Block Grant Synar
Report Format, FFY 2022-2024--(OMB No. 0930-0222)--Extension
Section 1926 of the Public Health Service Act [42 U.S.C. 300x-26]
stipulates that Substance Abuse Prevention and Treatment Block Grant
(SABG) funding agreements for alcohol
[[Page 466]]
and drug abuse programs for fiscal year 1994 and subsequent fiscal
years require states to have in effect a law providing that it is
unlawful for any manufacturer, retailer, or distributor of tobacco
products to sell or distribute any such product to any individual under
the age of 21. This section further requires that states conduct
annual, random, unannounced inspections to ensure compliance with the
law; that the state submit annually a report describing the results of
the inspections, the activities carried out by the state to enforce the
required law, the success the state has achieved in reducing the
availability of tobacco products to individuals under the age of 21,
and the strategies to be utilized by the state for enforcing such law
during the fiscal year for which the grant is sought.
Before making an award to a state under the SABG, the Secretary
must make a determination that the state has maintained compliance with
these requirements. If a determination is made that the state is not in
compliance, penalties shall be applied. According to Public Law 116-94
(``Tobacco 21''), signed on December 20, 2019, penalties are capped at
10 percent. Respondents include the 50 states, the District of
Columbia, the Commonwealth of Puerto Rico, the U.S. Virgin Islands,
Guam, American Samoa, the Commonwealth of the Northern Mariana Islands,
Palau, Micronesia, and the Marshall Islands. Red Lake Indian Tribe is
not subject to tobacco requirements.
Regulations that implement this legislation are at 45 CFR 96.130,
are approved by OMB under control number 0930-0163, and require that
each state submit an annual Synar report to the Secretary describing
their progress in complying with section 1926 of the PHS Act. The Synar
report, due December 31 following the fiscal year for which the state
is reporting, describes the results of the inspections and the
activities carried out by the state to enforce the required law; the
success the state has achieved in reducing the availability of tobacco
products to individuals under the age of 21; and the strategies to be
utilized by the state for enforcing such law during the fiscal year for
which the grant is sought. SAMHSA's Center for Substance Abuse
Prevention will request an extension of OMB approval of the current
report format associated with section 1926 (42 U.S.C. 300x-26) to 2024.
Extending OMB approval of the current report format will continue to
facilitate consistent, credible, and efficient monitoring of Synar
compliance across the states.
---------------------------------------------------------------------------
\1\ Red Lake Indian Tribe is not subject to tobacco
requirements.
Annual Reporting Burden
----------------------------------------------------------------------------------------------------------------
Number of Total
45 CFR citation respondents Responses per number of Hours per Total hour
\1\ respondents responses response burden
----------------------------------------------------------------------------------------------------------------
Annual Report (Section 1--States and 59 1 59 15 885
Territories) 96.130(e)(1-3).............
State Plan (Section II--States and 59 1 59 3 177
Territories) 6.130(e)(4,5)96.130(g).....
----------------------------------------------------------------------
Total................................ 59 .............. 118 ........... 1,062
----------------------------------------------------------------------------------------------------------------
Written comments and recommendations for the proposed information
collection should be sent within 30 days of publication of this notice
to www.reginfo.gov/public/do/PRAMain. Find this particular information
collection by selecting ``Currently under 30-day Review--Open for
Public Comments'' or by using the search function.
Carlos Graham,
Reports Clearance Officer.
[FR Doc. 2021-28564 Filed 1-4-22; 8:45 am]
BILLING CODE 4162-20-P